Literature DB >> 35275738

Effects of Regular/Dilute Proparacaine Anesthetic Eye Drops in Combination with Ophthalmic Antibiotics on Corneal Wound Healing.

Eric Zhang1,2, Suneel Gupta1,3, Evan Olson1,2, Prashant R Sinha1,3, Nathan P Hesemann1,2, Fredrick W Fraunfelder2, Rajiv R Mohan1,2,3.   

Abstract

Purpose: Topical, local anesthetic eye drops in conjunction with antibiotics are commonly used to reduce ocular pain and treat patients in emergency clinics; however, their effects on corneal healing are poorly understood. This study examined whether regular or diluted proparacaine eye drops given in combination with common ophthalmic antibiotics affect corneal wound healing parameters using in vitro and in vivo models.
Methods: Primary human corneal fibroblasts generated from donor corneas and New Zealand white rabbits were used. Regular (0.5%) and diluted (0.05%) proparacaine eye drops, twice daily for 3 days, were applied to cultures and rabbit eyes, with or without ophthalmic antibiotics (polymyxin B sulfate and trimethoprim). Trypan blue, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), and scratch wound assays measured cellular viability, proliferation, and migration, respectively, in vitro. Slit lamp biomicroscopy, tonometry, fluorescein eye test, hematoxylin and eosin (H&E) staining, and 4',6-diamidino-2-phenylindole (DAPI) immunofluorescence were used for in vivo studies.
Results: Both regular and diluted proparacaine affected wound healing response in the cornea in vitro and in vivo in a time-dependent manner. Adjunct antibiotic treatments had additive effects characterized by reduced corneal fibroblast viability, proliferation, and migration in vitro and corneal epithelial recovery in vivo. Regular proparacaine with antibiotics showed most pronounced effects on corneal wound healing parameters, and diluted proparacaine without antibiotics had minimal negative effects in vitro and in vivo.
Conclusion: Both methods of regular (0.5%) and diluted (0.05%) proparacaine topical application to the cornea are safe, but impede corneal wound healing in vitro and in vivo. Adjunct antibiotic treatments had additive negative effects on corneal wound repair.

Entities:  

Keywords:  cornea healing; corneal epithelium; proparacaine; topical anesthetics

Mesh:

Substances:

Year:  2022        PMID: 35275738      PMCID: PMC9048177          DOI: 10.1089/jop.2021.0116

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.850


  31 in total

1.  Topical anaesthetic in the treatment of corneal epithelial defects: What are the risks?

Authors:  Rogan Fraser; Mark Walland; Elsie Chan; Carmel Crock
Journal:  Aust J Gen Pract       Date:  2019-08

2.  An Observational Study to Determine Whether Routinely Sending Patients Home With a 24-Hour Supply of Topical Tetracaine From the Emergency Department for Simple Corneal Abrasion Pain Is Potentially Safe.

Authors:  Neil Waldman; Ben Winrow; Ian Densie; Andrew Gray; Scott McMaster; George Giddings; John Meanley
Journal:  Ann Emerg Med       Date:  2017-05-05       Impact factor: 5.721

3.  Topical anesthetic abuse keratopathy: a commonly overlooked health care problem.

Authors:  Ayse Yagci; Banu Bozkurt; Sait Egrilmez; Melis Palamar; Banu Turgut Ozturk; Hamiyet Pekel
Journal:  Cornea       Date:  2011-05       Impact factor: 2.651

Review 4.  Toxicity of topical ophthalmic anesthetics.

Authors:  Michelle Patel; Frederick W Fraunfelder
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-04-25       Impact factor: 4.481

5.  Management of Ocular Trauma in Emergency (MOTE) Trial: A pilot randomized double-blinded trial comparing topical amethocaine with saline in the outpatient management of corneal trauma.

Authors:  Joseph Y S Ting; Kenneth J Barns; John L Holmes
Journal:  J Emerg Trauma Shock       Date:  2009-01

Review 6.  Mechanisms of Corneal Pain and Implications for Postoperative Pain After Laser Correction of Refractive Errors.

Authors:  Renato Garcia; Daniel C de Andrade; Manoel J Teixeira; Siro S Nozaki; Samir J Bechara
Journal:  Clin J Pain       Date:  2016-05       Impact factor: 3.442

Review 7.  Toxicities of topical ophthalmic anesthetics.

Authors:  Hall T McGee; F W Fraunfelder
Journal:  Expert Opin Drug Saf       Date:  2007-11       Impact factor: 4.250

8.  Prospective, randomized, contralateral eye comparison of tetracaine and proparacaine for pain control in laser in situ keratomileusis and photorefractive keratectomy.

Authors:  Majid Moshirfar; Mark D Mifflin; Michael V McCaughey; Adam J Gess
Journal:  Clin Ophthalmol       Date:  2014-06-26

Review 9.  Acanthamoeba keratitis - Clinical signs, differential diagnosis and treatment.

Authors:  Nóra Szentmáry; Loay Daas; Lei Shi; Kornelia Lenke Laurik; Sabine Lepper; Georgia Milioti; Berthold Seitz
Journal:  J Curr Ophthalmol       Date:  2018-10-19

10.  A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study.

Authors:  Ratnakar Tripathi; Praveen K Balne; Nishant R Sinha; Lynn M Martin; Sabeeh Kamil; James R Landreneau; Suneel Gupta; Jason T Rodier; Prashant R Sinha; Nathan P Hesemann; Alexandria C Hofmann; Michael K Fink; Shyam S Chaurasia; Rajiv R Mohan
Journal:  Transl Vis Sci Technol       Date:  2020-11-02       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.